Our mission is to make the world healthier, one breath at a time!
Calmly is transforming addiction recovery and stress management with a science-backed, nicotine-free relaxation device. Designed to mimic smoking behaviors, it promotes deep breathing and stimulates the vagus nerve for natural stress relief—without batteries, nicotine, or harmful substances. Using patented technology, it delivers non-visible, natural aromas to engage the olfactory system, providing a safe and effective alternative to vaping and smoking.
With vaping addiction on the rise, particularly among young adults, and increasing awareness of its health risks, Calmly offers a timely and innovative solution. Our intellectual property portfolio spans NZ, AU, UK, and the USA, positioning us as a leader in the growing wellness market. Through continuous innovation and consumer trust, Calmly is committed to shaping a healthier, addiction-free future.
Vaping
Smoking
Anxiety & Stress
Understanding the Opportunity
Breathe Easy With Calming Device
Calmly will target two key streams, “Break the Habit” and “Reduce Anxiety / Stress"
Please see key documents for the Pitch Deck.
To watch the pitch and Q&A from the investor evening, click on the video here.
If you would like to view their data room, please click here.
Live q&a word document with the founder is here.
To indicate your interest in this deal, please click the invest button above. You are able to change or withdraw your order prior to the capital raise ending.
This deal is arranged through Mainland Angel Investors (MAI), and this page is maintained by MAI. The offer has been made available to you as MAI believes you are a wholesale investor and member of MAI. Neither MAI nor Catalist makes any representation as to any lack of errors or omissions in the investment information provided. If you believe there is any inaccuracy in these records, please contact Camille at Camille@mainlandangels.nz in the first instance.